Synagis (Palivizumab) - Drug Interactions, Contraindications, Overdosage

Rx drug information, pharmaceutical research, clinical trials, news, and more

Drugs by Name

Drugs by Condition

Drugs by Category

Alerts

Synagis Rx

Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information Active Ingredients Adverse Event Reports

Synagis News

News in Media Published Studies Curr't Clinical Trials

Nutrilib.com A comprihensive source of nutritional information

DRUG INTERACTIONS

SYNAGIS drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

OVERDOSAGE

No data from clinical studies are available on overdosage. No toxicity was observed in rabbits administered a single intramuscular or subcutaneous injection of Synagis® at a dose of 50 mg/kg.

CONTRAINDICATIONS

Synagis® should not be used in pediatric patients with a history of a severe prior reaction to Synagis® or other components of this product.

Page last updated: 2006-01-05

-- advertisement --

We comply with
HONcode standard.
Verify here.

Home | About Us | Contact Us | Site usage policy | Privacy policy